carbinoxamine maleate

FDA Drug Profile — RyVent

carbinoxamine maleate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including RyVent. Available dosage form: tablet.

Drug Details

Generic Name
carbinoxamine maleate
Brand Names
RyVent
Application Number
ANDA207484
Sponsor
Carwin Pharmaceutical Associates, LLC
NDC Codes
1
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
CARBINOXAMINE MALEATE

Indications and Usage

1 INDICATIONS AND USAGE Karbinal ER is indicated for adults and pediatric patients 2 years of age and older for the symptomatic treatment of: Seasonal and perennial allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema Dermatographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled Amelioration of the severity of allergic reactions to blood or plasma Karbinal ER is indicated for adults and pediatric patients 2 years of age and older for the symptomatic treatment of: Seasonal and perennial allergic rhinitis ( 1 ) Vasomotor rhinitis ( 1 ) Allergic conjunctivitis due to inhalant allergens and foods ( 1 ) Mild, uncomplicated allergic skin manifestations of urticaria and angioedema ( 1 ) Dermatographism ( 1 ) As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled ( 1 ) Amelioration of the severity of allergic reactions to blood or plasma ( 1 )